These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37779008)

  • 41. Providing patient care through community pharmacies in the UK: policy, practice, and research.
    Noyce PR
    Ann Pharmacother; 2007 May; 41(5):861-8. PubMed ID: 17456540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Description and Evaluation of an MPharm Practice-based Experience Pilot Program.
    Winn P; Turner CJ
    Am J Pharm Educ; 2016 Nov; 80(9):151. PubMed ID: 28090100
    [No Abstract]   [Full Text] [Related]  

  • 43. Formation of a statewide community pharmacy practice-based research network: Pharmacist opinions on research participation and engagement.
    Li JS; Blake V; George S; Carroll JC; Somma McGivney MA; Coley KC
    J Am Pharm Assoc (2003); 2020; 60(6):951-956. PubMed ID: 32782210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Maintenance of Clinical Expertise and Clinical Research by the Clinical Professors at Gifu Pharmaceutical University].
    Tachi T; Noguchi Y; Teramachi H
    Yakugaku Zasshi; 2017; 137(1):3-8. PubMed ID: 28049892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [THE PHARMACIST IN INDUSTRY].
    LOPEZABENTE A
    An Real Acad Farm; 1965; 31():89-106. PubMed ID: 14339617
    [No Abstract]   [Full Text] [Related]  

  • 46. A Cross-Sectional Study on Pharmacy Students' Career Choices in the Light of Saudi Vision 2030: Will Community Pharmacy Continue to Be the Most Promising, but Least Preferred, Sector?
    Almaghaslah D; Alsayari A; Almanasef M; Asiri A
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33926047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
    Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
    Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective analysis of patient care activities in a community pharmacy mental illness and addictions program.
    Haslam L; Gardner DM; Murphy AL
    Res Social Adm Pharm; 2020 Apr; 16(4):522-528. PubMed ID: 31327736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a community-academic collaborative pharmacy residency program.
    Mnatzaganian CL; Morello CM; Sarino L; Kuo GM
    Am J Health Syst Pharm; 2019 Jul; 76(14):1079-1085. PubMed ID: 31415687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Promotion of Pharmaceutical Care and Sciences: Focus of the Japanese Society of Pharmaceutical Health Care and Sciences].
    Sasaki H
    Yakugaku Zasshi; 2019; 139(3):405-410. PubMed ID: 30828019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community pharmacy-level factors associated with medical and nursing home facility collaboration in Japan.
    Ino Y; Shimauchi A; Tachi T; Noguchi Y; Sakai C; Iguchi K; Kano A; Teramachi H
    Pharmazie; 2019 Oct; 74(10):630-638. PubMed ID: 31685091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y; Sunderland B; Hughes J
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with the intensity of government remunerated and unremunerated service provision in community pharmacies.
    Czarniak P; Krass I; Sunderland B; Sim TF; Carter S
    Res Social Adm Pharm; 2021 Sep; 17(9):1614-1622. PubMed ID: 33423903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Report of the 2022-2023 AACP Professional Affairs Standing Committee: Focused Integration of Community-Based Pharmacy Practice Within the AACP Transformation Center.
    Mehta B; Smith MG; Bacci J; Brooks A; Dopp A; Groves B; Hritcko P; Kebodeaux C; Law AV; Marciniak MW; McGivney MA; Steinkopf M; Traylor C; Bradley-Baker LR
    Am J Pharm Educ; 2023 Aug; 87(8):100561. PubMed ID: 37423388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacists' participation in the development of an experiential program.
    O'Brocta R
    J Pharm Pract; 2010 Aug; 23(4):371-3. PubMed ID: 21507838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Community pharmacy-based injectable naltrexone service delivery models and best practices.
    Ford JH; Gilson AM; Bryan G; Augustine C; Gassman M; Mott DA
    Res Social Adm Pharm; 2021 Jul; 17(7):1332-1341. PubMed ID: 33268242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rural pharmacy in Canada: pharmacist training, workforce capacity and research partnerships.
    Soon JA; Levine M
    Int J Circumpolar Health; 2011 Sep; 70(4):407-18. PubMed ID: 21924009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.